Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

Preliminary data regarding outcomes for pediatric patients with inflammatory bowel disease during the coronavirus disease 2019 outbreak are reassuring

No Treatment Change Needed for Peds IBD During COVID-19 Pandemic

0
Authors recommend continuing inflammatory bowel disease treatment, including biologics
The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision. Sahlgrenska University Hospital is one of those facilities. It stopped the use of chloroquine in the treatment of COVID-19 about two weeks ago.

Side Effects Seen With Use of Chloroquine Against COVID-19

0
Some Swedish hospitals have stopped using the antimalarial drug due to severity of side effects
Hydroxychloroquine can shorten time to clinical recovery and promote pneumonia absorption among patients with coronavirus disease 2019

Hydroxychloroquine Can Shorten Time to Recovery in COVID-19

0
HCQ shortened body temperature recovery time and cough remission time versus standard treatment
Older patients taking five or more medications in the six months before intravenous chemotherapy are at higher risk for postchemotherapy inpatient hospitalizations

Polypharmacy Ups Postchemo Hospitalization Risk in Seniors

0
Findings seen in older patients with prostate, breast, and lung cancers
Liraglutide plus lifestyle therapy results in a significantly greater reduction in body mass index standard-deviation score than placebo among adolescents with obesity

ENDO: Liraglutide May Benefit Adolescents With Obesity

0
Reduction in BMI standard-deviation score greater for liraglutide + lifestyle therapy versus placebo
In a joint statement released by the American Medical Association

Doctors, Hospitals, Pharmacies Warned Not to Stockpile Meds

0
Professional societies issue stern warning not to inappropriately prescribe meds for COVID-19
Thirty-six months of treatment with immediate-release isradipine does not slow clinical progression of early-stage Parkinson disease

Isradipine Does Not Slow Early Parkinson Disease Progression

0
Change in total Unified Parkinson's Disease Rating Scale score similar for isradipine versus placebo
For women with early breast cancer receiving anthracyclines or trastuzumab

ACC: Statins Cut Heart Failure Risk in Early Breast Cancer Treatment

0
Risk for heart failure hospital visit declined with statins for women receiving anthracyclines, trastuzumab
Amongpatients with multidrug-resistant HIV-1 infection who have limited therapy options

Fostemsavir Active in Multidrug-Resistant HIV-1 Infection

0
Reduction in HIV-1 RNA level significantly greater for fostemsavir versus placebo in randomized cohort
For patients with transfusion-dependent β-thalassemia

Reduction Noted in Transfusion Burden With Luspatercept

0
Reduction seen with luspatercept versus placebo for patients with transfusion-dependent β-thalassemia